Literature DB >> 10875136

[The value of core decompression in treatment of femur head necrosis].

W Schneider1, M Breitenseher, A Engel, K Knahr, H Plenk, S Hofmann.   

Abstract

Core decompression of the necrotic area for treatment of idiopathic osteonecrosis of the femoral head was developed and published by Ficat and Arlet in 1962 within the scope of their "Functional exploration of bone". The mode of action is attributed to a reduction of the intramedullary pressure in the bony compartment of the femoral head. The possibilities of repair and bone regeneration following core decompression are still discussed controversially. Core decompression is a common but not generally accepted procedure in the treatment of idiopathic osteonecrosis of the femoral head. After first publications of positive mid- and long-term effects, some subsequent studies judged it as an ineffective and high-risk method. Analysis of the literature shows that the effectiveness of core decompression depends on the stage of osteonecrosis at the time of surgical intervention. Prognosis is influenced by the extent and location of the necrotic area, the presence and amount of head depression, and continued risk factors--mainly corticoid medication. The best prognosis can be given for patients with a small, medial-centrally located necrosis without head depression. The classification according to Ficat appears to be insufficient, as the extent and localization of the necrotic area are not assessed. Magnetic resonance imaging has become a diagnostic gold standard, as radiographic diagnosis showed poor sensitivity and specificity, especially in the early stages of the disease. As an essential part, MRI was integrated into the new classification of the "Association Internationale de Recherche sur la Circulation Osseuse" (ARCO). On account of the literature and our own experience, treatment by core decompression can be recommended in cases of reversible early stages of osteonecrosis (ARCO 1), as well as in those cases of irreversible early stages (ARCO 2) that show a medial or central location of the necrosis with an extent of less than 30% of the femoral head. Once the disease reaches the irreversible early stage, complete recovery cannot be expected. In these cases only reduction of pain and retardation of the natural course of the osteonecrosis are possible to gain time until total hip replacement is unavoidable.

Entities:  

Mesh:

Year:  2000        PMID: 10875136     DOI: 10.1007/s001320050463

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  9 in total

1.  [Growth and differentiation factor 5 (GDF-5) composite improves the healing of necrosis of the femoral head in a sheep model. Analysis of an animal model].

Authors:  H-G Simank; F Herold; M Schneider; U Maedler; R Ries; C Sergi
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

Review 2.  [Osteonecrosis of the hip in adults].

Authors:  S Hofmann; J Kramer; H Plenk
Journal:  Orthopade       Date:  2005-02       Impact factor: 1.087

Review 3.  [Total hip replacement in avascular femoral head necrosis].

Authors:  M Betsch; M Tingart; A Driessen; V Quack; B Rath
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

Review 4.  Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge.

Authors:  Michaela Kuhlen; Marina Kunstreich; Kathinka Krull; Roland Meisel; Arndt Borkhardt
Journal:  Blood Adv       Date:  2017-06-13

5.  Treatment of Femoral Head Osteonecrosis (Stages 2B, 3 Ficat) Through Open Direct Core Decompression by Allograft Impaction and Light Bulb Technique.

Authors:  Shahram Shiravani Brojeni; Hamid Hesarikia; Amirhossein Rahimnia; Mohammad Kazem Emami Meybodi; Alireza Rahimnia
Journal:  Arch Bone Jt Surg       Date:  2020-09

Review 6.  [Femoral head necrosis].

Authors:  J Kramer; G Scheurecker; A Scheurecker; A Stöger; A Huber; S Hofmann
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

7.  Titanium alloy cage implantation for the treatment of ischemic necrosis of femoral head in dogs.

Authors:  Ruiying Wang; Yan Gao; Shuhua Yang; Cao Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

8.  Core Decompression and Autologous Bone Marrow Concentrate for Treatment of Femoral Head Osteonecrosis: A Randomized Prospective Study.

Authors:  Wojciech Pepke; Philip Kasten; Nicholas A Beckmann; Patricia Janicki; Marcus Egermann
Journal:  Orthop Rev (Pavia)       Date:  2016-03-21

9.  What are the outcomes of core decompression in patients with avascular necrosis? Protocol for a systematic review.

Authors:  Octavian Andronic; Haitham Shoman; Ori Weiss; Vikas Khanduja
Journal:  F1000Res       Date:  2020-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.